These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37249223)

  • 21. Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
    Ryschich E; Cebotari O; Fabian OV; Autschbach F; Kleeff J; Friess H; Bierhaus A; Büchler MW; Schmidt J
    Tissue Antigens; 2004 Dec; 64(6):696-702. PubMed ID: 15546343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma.
    Li HX; Liu TR; Tu ZX; Xie CB; Wen WP; Sun W
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
    Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
    Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
    McGranahan N; Rosenthal R; Hiley CT; Rowan AJ; Watkins TBK; Wilson GA; Birkbak NJ; Veeriah S; Van Loo P; Herrero J; Swanton C;
    Cell; 2017 Nov; 171(6):1259-1271.e11. PubMed ID: 29107330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
    Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K
    Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
    Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
    Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
    Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
    Front Immunol; 2022; 13():969034. PubMed ID: 36466881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
    Lu H; Dai W; Guo J; Wang D; Wen S; Yang L; Lin D; Xie W; Wen L; Fang J; Wang Z
    Front Immunol; 2020; 11():573920. PubMed ID: 33101298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA and MICA associations with head and neck squamous cell carcinoma.
    Reinders J; Rozemuller EH; Otten HG; van der Veken LT; Slootweg PJ; Tilanus MG
    Oral Oncol; 2007 Mar; 43(3):232-40. PubMed ID: 16857416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma.
    Zhang J; Liu Y; Xia L; Zhen J; Gao J; Atsushi T
    Comput Biol Med; 2023 Oct; 165():107459. PubMed ID: 37713790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of non-classical and chain-related human leukocyte antigen polymorphisms in laryngeal squamous cell carcinoma.
    Ormandjieva A; Yordanov S; Stoyanov H; Deliverska E; Shivarov V; Ivanova M
    Mol Biol Rep; 2023 Sep; 50(9):7245-7252. PubMed ID: 37418079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
    Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
    Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma.
    Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.